Evidence map›Paper›PMID 22430020›Full record

Trial reportThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry2012

Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset.

Deanna M Barch, Gina DʼAngelo, Carl Pieper, Consuelo H Wilkins, Kathleen Welsh-Bohmer, Warren Taylor, Keith S Garcia, Kenneth Gersing, P Murali Doraiswamy, Yvette I Sheline

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 4 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 4 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. A Systematic Review of Antidepressants and Psychotherapy Commonly Used in the Treatment of Late Life Depression for Their Effects on Cognition.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. The efficacy of transcranial random noise stimulation (tRNS) on mood may depend on individual differences including age and trait mood.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2018
    Trial
  6. Accelerated Cognitive Decline in Late Life Depression: The Role of Amyloid-β, Cortico-Limbic Volume, and White Matter Hyperintensities.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Impact of cardiovascular risk factors on the relationships of physical activity with mood and cognitive function in a diverse sample.Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition · 2023
    Article
  11. Models of depressive pseudoamnestic disorder.Alzheimer's & dementia (New York, N. Y.) · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Do Antidepressants Increase the Risk of Dementia?The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Deanna M BarchDepartment of Psychology, Washington University School of Medicine, St. Louis, MO, USA.
Gina DʼAngelo
Carl Pieper
Consuelo H Wilkins
Kathleen Welsh-Bohmer
Warren Taylor
Keith S Garcia
Kenneth Gersing
P Murali Doraiswamy
Yvette I Sheline
Duke University · USWashington University in St. Louis · US

Funding

YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMESM01RR000036 · NCRR · WASHINGTON UNIVERSITY · PI POLONSKY, KENNETH S · 1985 to 2007
$25.4M
Treatment Outcomes of Vascular DepressionR01MH062158 · NIMH · DUKE UNIVERSITY · PI DORAISWAMY, P. MURALI · 2001 to 2005
$1.7M
Treatment Outcome of Vascular DepressionR01MH060697 · NIMH · WASHINGTON UNIVERSITY · PI SHELINE, YVETTE I · 2001 to 2005
$1.7M
STATISTICAL METHODS TO MODEL SPATIOTEMPORAL BRAIN FUNCTIONAL PATHWAYS IN DEMENTIAK25AG035062 · NIA · WASHINGTON UNIVERSITY · PI D'ANGELO, GINA M · 2010 to 2013
$556k
NCRR NIH HHS M01 RR000036NCRR NIH HHS RR00036NIA NIH HHS K25 AG035062NIMH NIH HHS R01 MH060697NIMH NIH HHS R01 MH062158NIMH NIH HHS R01 MH60697PHS HHS K24 65421
6 · The paper itself

Abstract

objectivesTo test the hypothesis that the degree of vascular burden and/or age of onset may influence the degree to which cognition can improve during the course of treatment in late-life depression.

designMeasurement of cognition both before and following 12 weeks of treatment with sertraline.

settingUniversity medical centers (Washington University and Duke University).

participantsOne hundred sixty-six individuals with late-life depression.

interventionSertraline treatment. MEASUREMENTS: The cognitive tasks were grouped into five domains (language, processing speed, working memory, episodic memory, and executive function). We measured vascular risk using the Framingham Stroke Risk Profile measure. We measured T2-based white matter hyperintensities using the Fazekas criteria.

resultsBoth episodic memory and executive function demonstrated significant improvement among adults with late-life depression during treatment with sertraline. Importantly, older age, higher vascular risk scores, and lower baseline Mini-Mental State Examination scores predicted less change in working memory. Furthermore, older age, later age of onset, and higher vascular risk scores predicted less change in executive function.

conclusionsThese results have important clinical implications in that they suggest that a regular assessment of vascular risk in older adults with depression is necessary as a component of treatment planning and in predicting prognosis, both for the course of the depression itself and for the cognitive impairments that often accompany depression in later life.

Indexed as

AgedAge of OnsetAntidepressive AgentsCognition DisordersDepressionExecutive FunctionFemaleHumansMaleMemoryMental Status ScheduleSertralineSeverity of Illness IndexTreatment OutcomeVascular DiseasesAntidepressive AgentsSertraline

Identifiers

PMID22430020
PMCPMC3382028
OpenAlexW2106744889

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.